These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36641879)

  • 41. Risk factors associated with diabetic foot ulcer-free survival in patients with diabetes.
    Yazdanpanah L; Shahbazian H; Nazari I; Hesam S; Ahmadi F; Cheraghian B; Arti HR; Mohammadianinejad SE
    Diabetes Metab Syndr; 2018 Nov; 12(6):1039-1043. PubMed ID: 30168426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cohort study of diabetic patients and diabetic foot ulceration patients in China.
    Jiang Y; Wang X; Xia L; Fu X; Xu Z; Ran X; Yan L; Li Q; Mo Z; Yan Z; Ji Q; Li Q
    Wound Repair Regen; 2015; 23(2):222-30. PubMed ID: 25682850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time.
    Mizrak HI; Hansen TW; Andersen JA; Rossing P; Rasmussen A; Hansen CS
    J Diabetes Complications; 2022 Dec; 36(12):108353. PubMed ID: 36370668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D Status in a Bulgarian Population With Type 2 Diabetes and Diabetic Foot Ulcers.
    Todorova AS; Jude EB; Dimova RB; Chakarova NY; Serdarova MS; Grozeva GG; Tsarkova PV; Tankova TI
    Int J Low Extrem Wounds; 2022 Dec; 21(4):506-512. PubMed ID: 33094656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran.
    Yazdanpanah L; Shahbazian H; Nazari I; Arti HR; Ahmadi F; Mohammadianinejad SE; Cheraghian B; Latifi SM
    Diabetes Metab Syndr; 2018 Jul; 12(4):519-524. PubMed ID: 29602761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study.
    Zantour B; Bouchareb S; El Ati Z; Boubaker F; Alaya W; Kossomtini W; Sfar MH
    BMC Endocr Disord; 2020 Aug; 20(1):128. PubMed ID: 32831070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting the Risk of Diabetic Foot Ulcers From Diabetics With Dysmetabolism: A Retrospective Clinical Trial.
    Jiang M; Gan F; Gan M; Deng H; Chen X; Yuan X; Huang D; Liu S; Qin B; Wei Y; Su S; Bo Z
    Front Endocrinol (Lausanne); 2022; 13():929864. PubMed ID: 35903284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortality in 98 type 1 diabetes mellitus and type 2 diabetes mellitus: Foot ulcer location is an independent risk determinant.
    Schofield H; Haycocks S; Robinson A; Edmonds M; Anderson SG; Heald AH
    Diabet Med; 2021 Oct; 38(10):e14568. PubMed ID: 33772856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implication of Low Plasma Arginine among Patients with Diabetic Foot Ulcer (DFU).
    Hamad NA; Eltayeb LB; Yassin HM
    Pak J Biol Sci; 2024 Jan; 27(1):46-51. PubMed ID: 38413397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Standard complication screening information can be used for risk assessment for first time foot ulcer among patients with type 1 and type 2 diabetes.
    Hangaard S; Rasmussen A; Almdal T; Nielsen AA; Nielsen KE; Siersma V; Holstein P
    Diabetes Res Clin Pract; 2019 May; 151():177-186. PubMed ID: 31004675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.
    Umapathy D; Dornadula S; Rajagopalan A; Murthy N; Mariappanadar V; Kesavan R; Kunka Mohanram R
    J Vasc Surg; 2018 Apr; 67(4):1283-1291.e2. PubMed ID: 28736121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
    Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
    BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study of 26,809 patients from 5 primary hospitals in China.
    Liu Z; Li X; Wang Y; Song Y; Liu Q; Gong J; Fan W; Lv C; Cao C; Zhao W; Xiao J
    Front Endocrinol (Lausanne); 2023; 14():1133290. PubMed ID: 36967757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts.
    Jiang W; Wang J; Shen X; Lu W; Wang Y; Li W; Gao Z; Xu J; Li X; Liu R; Zheng M; Chang B; Li J; Yang J; Chang B
    Diabetes Care; 2020 Apr; 43(4):925-933. PubMed ID: 32198286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet.
    Sämann A; Pofahl S; Lehmann T; Voigt B; Victor S; Möller F; Müller UA; Wolf G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):335-9. PubMed ID: 22421981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort.
    Hirano T; Satoh N; Kodera R; Hirashima T; Suzuki N; Aoki E; Oshima T; Hosoya M; Fujita M; Hayashi T; Ito Y
    J Diabetes Investig; 2022 Apr; 13(4):657-667. PubMed ID: 34665936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of sleep duration and changes in body mass index on diabetic kidney disease: a prospective cohort study.
    Liu C; Zhang J; Wei X; Shi J; Fang Q; Zhou W; Sun L; Hu Z; Hong J; Gu W; Wang W; Peng Y; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1278665. PubMed ID: 37964958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcin.
    Kacso AC; Bondor CI; Coman AL; Potra AR; Georgescu CE
    Scand J Clin Lab Invest; 2016; 76(3):217-25. PubMed ID: 26922969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.